Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
3.18
|
3.29
|
3.22
|
3.13
|
3.25
|
3.17
|
|
|
130 798.16
|
274.00
|
3.25
|
3.28
|
3.35
|
3.22
|
3.35
|
3.22
|
|
|
59 087.94
|
197.00
|
3.38
|
3.45
|
3.40
|
3.37
|
3.57
|
3.385
|
|
|
90 356.04
|
286.00
|
3.32
|
3.40
|
3.27
|
3.27
|
3.45
|
3.41
|
|
|
125 202.92
|
446.00
|
3.28
|
3.33
|
3.37
|
3.24
|
3.41
|
3.27
|
|
|
149 007.39
|
370.00
|
3.29
|
3.33
|
3.53
|
3.18
|
3.53
|
3.235
|
|
|
122 675.89
|
527.00
|
3.43
|
3.59
|
3.47
|
3.44
|
3.535
|
3.44
|
|
|
20 923.55
|
144.00
|
3.42
|
3.54
|
3.62
|
3.45
|
3.62
|
3.47
|
|
|
133 388.58
|
389.00
|
3.61
|
3.68
|
3.70
|
3.60
|
3.76
|
3.62
|
|
|
55 233.32
|
200.00
|
3.68
|
3.71
|
3.72
|
3.65
|
3.74
|
3.73
|
|
|
30 966.98
|
186.00
|
Tempest Therapeutics Inc. operates as a development-stage biotechnology company. The Company focuses on targeted and immune-eediated cancer therapies that modulate anti-tumor immunity pathways. Tempest Therapeutics serves customers worldwide.